SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

FMR LLC – ‘4’ for 4/17/24 re: Structure Therapeutics Inc.

On:  Friday, 4/19/24, at 2:13pm ET   ·   For:  4/17/24   ·   As:  Other   ·   Accession #:  950170-24-45901   ·   File #:  1-41608

Previous ‘4’:  ‘4’ on 3/18/24 for 3/14/24   ·   Latest ‘4’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/19/24  FMR LLC                           4          Other       1:10K  Structure Therapeutics Inc.       Donnelley … Solutions/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML     10K 
                Securities by an Insider -- ownership.xml/5.8


        

This ‘4’ Document is an XML Data File that may be rendered in various formats:

  Form 4    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
SEC Info℠ rendering:  Statement of Changes in Beneficial Ownership of Securities by an Insider
 

The SEC has not released XSLT Stylesheets needed to render this File’s XML Data as a Form.

This is our “Plain Text” rendering:
 
                                                                                                                                                                                
Ownership Document
 
Schema Version:  X0508
Document Type:  4
Period of Report:  4/17/24
Not Subject to Section 16?  Yes
Issuer:
Issuer CIK:  1888886
Issuer Name:  Structure Therapeutics Inc.
Issuer Trading Symbol:  GPCR
Reporting Owner:
Reporting Owner ID:
Owner CIK:  315066
Owner Name:  FMR LLC
Reporting Owner Address:
Owner Street 1:  245 SUMMER STREET
Owner Street 2:
Owner City:  BOSTON
Owner State:  MA
Owner ZIP Code:  02210
Owner State Description:
Reporting Owner Relationship:
Is Director?  No
Is Officer?  No
Is Ten Percent Owner?  No
Is Other?  Yes
Other Text:  See Remark 1
Aff 10b5 One?  No
Non-Derivative Table:
Non-Derivative Holding:
Security Title:
Value:  Ordinary Shares
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  45,120
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Non-Derivative Holding:
Security Title:
Value:  Ordinary Shares
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  530,814
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  F-Prime Capital Partners Life Sciences Fund VI LP
Derivative Table:
Derivative Holding:
Security Title:
Value:  American Depositary Shares
Conversion or Exercise Price:
Footnote ID:  F1
Exercise Date:
Footnote ID:  F1
Expiration Date:
Footnote ID:  F1
Underlying Security:
Underlying Security Title:
Value:  Ordinary Shares
Underlying Security Shares:
Value:  4,625,604
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  1,541,868
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  Shares held by persons and entities whose shares are subject to reporting by the undersigned
Derivative Holding:
Security Title:
Value:  American Depositary Shares
Conversion or Exercise Price:
Footnote ID:  F1
Exercise Date:
Footnote ID:  F1
Expiration Date:
Footnote ID:  F1
Underlying Security:
Underlying Security Title:
Value:  Ordinary Shares
Underlying Security Shares:
Value:  123
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  41
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  FIMM, LLC
Derivative Holding:
Security Title:
Value:  American Depositary Shares
Conversion or Exercise Price:
Footnote ID:  F1
Exercise Date:
Footnote ID:  F1
Expiration Date:
Footnote ID:  F1
Underlying Security:
Underlying Security Title:
Value:  Ordinary Shares
Underlying Security Shares:
Value:  8,199
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  2,733
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  F-Prime Capital Partners Life Sciences Advisors Fund VI LP
Derivative Holding:
Security Title:
Value:  American Depositary Shares
Conversion or Exercise Price:
Footnote ID:  F1
Exercise Date:
Footnote ID:  F1
Expiration Date:
Footnote ID:  F1
Underlying Security:
Underlying Security Title:
Value:  Ordinary Shares
Underlying Security Shares:
Value:  96,507
Post-Transaction Amounts:
Shares Owned Following Transaction:
Value:  32,169
Ownership Nature:
Direct or Indirect Ownership:
Value:  I
Nature of Ownership:
Value:  F-Prime Capital Partners Life Sciences Fund VI LP
Footnotes:
Footnote - F1:  Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.
Remarks:  Remark 1: Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein. Remark 3: F-Prime Capital Partners Life Sciences Advisors Fund VI LP (FPCPLSA) is the general partner of F-Prime Capital Partners Life Sciences Fund VI LP. FPCPLSA is solely managed by Impresa Management LLC, the managing member of its general partner and its investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family. FIMM, LLC is an indirect, wholly-owned subsidiary of FMR LLC.
Owner Signature:
Signature Name:  Bryan Comtois, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, and Abigail P. Johnson
Signature Date:  4/19/24


↑Top
Filing Submission 0000950170-24-045901   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 6:58:03.6pm ET